IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 320 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,158,948 | -9.8% | 25,550 | -18.4% | 0.14% | +47.4% |
| Q2 2023 | $1,284,239 | +12.9% | 31,300 | -1.6% | 0.10% | +6.6% |
| Q1 2023 | $1,137,426 | +55738.3% | 31,825 | -41.0% | 0.09% | -47.4% |
| Q4 2022 | $2,037 | -99.9% | 53,925 | -38.6% | 0.17% | -52.5% |
| Q3 2022 | $3,888,000 | +12.4% | 87,895 | -5.9% | 0.36% | +15.2% |
| Q2 2022 | $3,459,000 | -5.7% | 93,445 | -5.6% | 0.32% | +5.7% |
| Q1 2022 | $3,668,000 | +190.4% | 99,020 | +138.5% | 0.30% | +193.1% |
| Q4 2021 | $1,263,000 | +287.4% | 41,520 | +326.9% | 0.10% | +251.7% |
| Q3 2021 | $326,000 | – | 9,725 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |